Stated plainly: ERP · a GLP-1 receptor agonist. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
All questions
Newest first. 5.2k questions across 107 tags.
Setup, so nobody has to ask: SURMOUNT-4 · mazdutide. This has the shape of a fact but I cannot find its origin. What I found instead were three secondary sources all…
What I have: hydrolysis · room temperature. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know how…
Numbers first: 98.4% · Janoshik · 97.1% · PeptideMeter. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a…
Details up front: 2 mg · retatrutide. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know how…
Details up front: SWB · Xianning · Germany. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum…
What I have: TRIUMPH-1 · constipation. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
Details up front: 30 mg · retatrutide. This should be a straightforward calculation and I keep getting two different answers. The numbers are arbitrary; the method is…
I have three data points across nine months, which I hope is enough to see a trend. This should be a straightforward calculation and I keep getting two different…
Numbers first: a sterility test · orforglipron. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum…
What I have: ApoB · retatrutide. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum viable version,…
The case in front of me: Chengdu · Germany. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single…
The case in front of me: GGT · liraglutide. I want to know whether this is a real physical effect or an artefact of how it is measured. What prompted the question is…
The case in front of me: magnesium · liraglutide. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would…
Concretely: ecnoglutide · mazdutide. I would like the axes of comparison first and the recommendation second. I have tried the first option and it works; the question…
Concretely: 40 °C · oral semaglutide. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone points me at one. Has…
The receptor pharmacology I can follow; the in vivo translation is where I lose the thread. Please show the division. I want to check my own against yours. I would…
For reference: liraglutide · 2.5 mg/mL. I would rather understand the derivation than memorise the outcome. Two people I asked gave two answers that differ by a…
I was sent a compounded multi-dose vial with a beyond-use date 90 days out, refrigerated, and a note saying the pharmacy is "PCAB accredited and USP 797 compliant".…
For reference: 4 mg · 2 mL. I would rather understand the derivation than memorise the outcome. Two people I asked gave two answers that differ by a factor of ten,…
The specifics, since they change the answer: potassium · three weeks · cagrilintide. An unexpected observation, and I would like a differential rather than…
For reference: 15 mg · 0.5 mL · phosphate-buffered diluent. I would rather understand the derivation than memorise the outcome. Two people I asked gave two answers…
The specifics, since they change the answer: 99.1% · ecnoglutide · WWB. I would like to define my thresholds before I have a result, for obvious reasons. I want a…
Stated plainly: dimerisation · a GLP-1 receptor agonist · minus 80 °C. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me…